How UPMC Hillman and Krystal Biotech will be working together on a new cancer treatment


It's the Pittsburgh-based biotech firm's first foray into oncology.

Previous Advent Therapeutics lands $3M NIH grant to advance therapy to benefit premature infants
Next Former CEO pleads guilty to lying to feds during $40M health care fraud investigation